Literature DB >> 11193569

Intestinal cell adhesion molecules. Liver-intestine cadherin.

R Gessner1, R Tauber.   

Abstract

The cadherin superfamily comprises a large number of cell adhesion molecules, several of which are expressed in the gastrointestinal tract. LI-cadherin represents a novel type of cadherin within the cadherin superfamily distinguished from other cadherins by structural and functional features described in this review. In the mouse and human, LI-cadherin is selectively expressed on the basolateral surface of enterocytes and goblet cells in the small and large intestine, whereas in the rat this cadherin is additionally detectable in hepatocytes. LI-cadherin is capable of mediating Ca(2+)-dependent homophilic cell-cell adhesion independent of interactions with the cytoskeleton, indicating that the adhesive function of this novel cadherin is complementary to that of E-cadherin and desmosomal cadherins co expressed in the intestinal mucosa.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11193569     DOI: 10.1111/j.1749-6632.2000.tb05236.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  28 in total

Review 1.  Association between cadherin-17 expression and pathological characteristics of gastric cancer: a meta-analysis.

Authors:  Zi-Wen Long; Meng-Long Zhou; Jing-Wei Fu; Xian-Qun Chu; Ya-Nong Wang
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Altered expression of a Li-cadherin in gastric cancer and intestinal metaplasia.

Authors:  Weiguo Dong; Qiongfang Yu; Yu Xu
Journal:  Dig Dis Sci       Date:  2007-01-17       Impact factor: 3.199

3.  Altered expression of TFF-1 and CES-2 in Barrett's Esophagus and associated adenocarcinomas.

Authors:  Charles A Fox; Lisa M Sapinoso; Hong Zhang; Wanghai Zhang; Howard L McLeod; Gina R Petroni; Tarun Mullick; Christopher A Moskaluk; Henry F Frierson; Garret M Hampton; Steven M Powell
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

4.  Knockdown of Li-cadherin increases metastatic behaviors of LoVo cells.

Authors:  Qiong-Fang Yu; Wei-Guo Dong; Jian-Lin Ren
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-04       Impact factor: 4.553

5.  Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer.

Authors:  Reiko Ito; Naohide Oue; Kazuhiro Yoshida; Kyoko Kunimitsu; Hirofumi Nakayama; Kei Nakachi; Wataru Yasui
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

6.  Simultaneous amperometric immunosensing of the metastasis-related biomarkers IL-13Rα2 and CDH-17 by using grafted screen-printed electrodes and a composite prepared from quantum dots and carbon nanotubes for signal amplification.

Authors:  Verónica Serafín; Alejandro Valverde; María Garranzo-Asensio; Rodrigo Barderas; Susana Campuzano; Paloma Yáñez-Sedeño; José M Pingarrón
Journal:  Mikrochim Acta       Date:  2019-06-10       Impact factor: 5.833

7.  Blockade of proliferation and migration of gastric cancer via targeting CDH17 with an artificial microRNA.

Authors:  Jin Zhang; Qi-Sheng Liu; Wei-Guo Dong
Journal:  Med Oncol       Date:  2011-06       Impact factor: 3.064

8.  Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.

Authors:  Hyuk-Joon Lee; Ki Taek Nam; Heae Surng Park; Min A Kim; Bonnie J Lafleur; Hiroyuki Aburatani; Han-Kwang Yang; Woo Ho Kim; James R Goldenring
Journal:  Gastroenterology       Date:  2010-04-13       Impact factor: 22.682

9.  The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer.

Authors:  Yun-Suhk Suh; Hyuk-Joon Lee; Eun-Jung Jung; Min-A Kim; Ki Taek Nam; James R Goldenring; Han-Kwang Yang; Woo Ho Kim
Journal:  Ann Surg Oncol       Date:  2011-11-03       Impact factor: 5.344

10.  Single nucleotide polymorphisms in the CDH17 gene of colorectal carcinoma.

Authors:  Ren-Yin Chen; Juan-Juan Cao; Juan Chen; Jian-Ping Yang; Xiao-Bo Liu; Guo-Qiang Zhao; Yu-Feng Zhang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.